| Apr 4 2019 |
Cleveland Clinic II – Why Can’t a Diagnostic Conclusion be a Practical Application of a Natural Law? |
Schwegman, Lundberg & Woessner, P.A. |
| Apr 4 2019 |
Washington Court of Appeals Upholds Multi-Million Dollar Fine for 5-Hour Energy Advertising Claims |
McDermott Will & Schulte LLP |
| Apr 4 2019 |
FDA Encourages Participation in Voluntary Plant Biotechnology Consultation Program and Revises Guidance on Voluntary Labeling of Foods Derived Plant Biotechnology |
Keller and Heckman LLP |
| Apr 4 2019 |
FDA Updates Guidance for CBD Products amid a New Round of Warning Letters and Announcement of Date for Public Hearing |
Wilson Elser Moskowitz Edelman & Dicker LLP |
| Apr 3 2019 |
340B Drug Ceiling Prices Now Available |
Dinsmore & Shohl LLP |
| Apr 3 2019 |
CMS’s New Part D Policies Address the Opioid Epidemic |
Mintz |
| Apr 3 2019 |
FDA Commissioner Gottlieb Says Agency Will Not Tolerate Deceptive Marketing of CBD Products; Issues Warning Letters |
Epstein Becker & Green, P.C. |
| Apr 3 2019 |
FDA Announces Public Hearing on Products Containing Cannabis or Cannabis-Derived Compounds |
McDermott Will & Schulte LLP |
| Apr 3 2019 |
FDA Announces New Steps to Advance Regulatory Framework for CBD Products |
Keller and Heckman LLP |
| Apr 2 2019 |
New Arkansas Law Defines Rice, Beef, Pork, and Meat |
Keller and Heckman LLP |
| Apr 2 2019 |
What is the Deal With TDF Drug and Truvada Lawsuits? |
Stark & Stark |
| Apr 2 2019 |
Federal Circuit Finds Endo Method Of Treatment Claims Satisfy 35 USC 101 |
Foley & Lardner LLP |
| Apr 1 2019 |
Bridging the Weeks by Gary DeWaal: March 18 – 29 and April 1, 2019 (Programmer’s Trial; Trade Reporting Headaches; Food Giants Settle Manipulation Enforcement Action) |
Katten |
| Apr 1 2019 |
FDA Silent on CBD Regulation at Cosmetics Conference, But Legislation May Be Imminent |
Mintz |
| Apr 1 2019 |
District Court Decision Rejects Commerce Clause Challenge to Missouri’s Retailer Wine Shipping Laws |
McDermott Will & Schulte LLP |
| Apr 1 2019 |
Public Consultation on EFSA’s Draft Assessment of 5 Phthalates Underway |
Keller and Heckman LLP |
| Apr 1 2019 |
U.S. Supreme Court to Consider Whether Courts Must Defer to an Agency’s Interpretation of its Regulations – a Judicial Policy That Recently Resulted in Dismissal of Litigation Over ‘No Sugar Added’ Claims on 100% Juices |
Keller and Heckman LLP |
| Mar 30 2019 |
Second Circuit Affirms “Snap” Removal Practice |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 29 2019 |
Endo v. Teva – Correlation Diagnostic Plus Treatment is Patent Eligible under s. 101 |
Schwegman, Lundberg & Woessner, P.A. |
| Mar 29 2019 |
OH SNAP! Supreme Court to Take on Meaning of Key FOIA Exemption |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 29 2019 |
FDA’s Premarket Voluntary Plant Biotechnology Consultation Program Provides Opportunity For Developers |
Bergeson & Campbell, P.C. |
| Mar 29 2019 |
FDA Announces Enforcement Discretion for Certain Commodities Related to Produce Safety Rule |
Keller and Heckman LLP |
| Mar 29 2019 |
Possession Of A Medical Marijuana Card Alone Does Not Prove Marijuana Use, Appeals Court Holds |
Jackson Lewis P.C. |
| Mar 29 2019 |
ISO Publishes Standard on Matrix of Properties and Measurement Techniques for Graphene and Related 2D Materials |
Bergeson & Campbell, P.C. |
| Mar 29 2019 |
Learned Intermediary Doctrine Protects Pharmacy from Liability for Failure to Warn of Prescription Drug Side Effects |
Wilson Elser Moskowitz Edelman & Dicker LLP |
| Mar 28 2019 |
New Jersey Legislature Cancels Vote to Legalize Recreational Marijuana |
Wilson Elser Moskowitz Edelman & Dicker LLP |
| Mar 28 2019 |
California Jury Awards $80 Million Verdict in Glyphosate Case |
Keller and Heckman LLP |
| Mar 28 2019 |
Pharmacies: DOJ Wins TRO to Immediately Suspend Registration for Controlled Substances |
Foley & Lardner LLP |
| Mar 27 2019 |
FDA’s Evolving “Compliance Policy” for Deemed Tobacco Products: What it Means for Your Business |
Keller and Heckman LLP |
| Mar 27 2019 |
MillerCoors Turns to Lanham Act to Nip Rival’s Ads in the “Bud” |
Bilzin Sumberg |
| Mar 27 2019 |
Novartis Hit with $1.5M Whistleblower Suit, Avoids Punitive Damages |
Stark & Stark |
| Mar 27 2019 |
KIND Petitions FDA to Update Nutrient Content Claim Regulations |
Keller and Heckman LLP |
| Mar 26 2019 |
EPA Updates New RT25 Data to Help Beekeepers and Farmers Protect Pollinators |
Bergeson & Campbell, P.C. |
| Mar 26 2019 |
Soda Tax Debate Continues |
Keller and Heckman LLP |
| Mar 25 2019 |
NNI Webinar Registration Available: Drivers of NanoEHS Research |
Bergeson & Campbell, P.C. |
